. . . . . . . . . . . . . "p(HGNC:LY96) -> path(MESHD:Sepsis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Recombinant soluble myeloid differentiation protein-2 (MD-2) complemented normal plasma and allowed LPS activation of epithelial cells to levels measured with \\\"septic\\\" plasma, whereas soluble MD-2-depleted plasma lost its effects." . . "Selventa" . . . . "2014-07-03T14:32:28.254+02:00"^^ . . .